Physician profile
Daniel Webb
NPI 1811259765
$2,452.90
in general payments reported to CMS, 2019-2025
13 companies · $1,501 in 2025
The $1,501 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $16.77 · 2024: $935 · 2025: $1,501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,006 · Education: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,005.94 |
| Education | $446.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $621.54 | 2024-2025 | |
| Janssen Biotech, INC. | $571.44 | 2024-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $401.31 | 2023-2025 | Odomzo, Blu-U |
| E.R. Squibb & Sons, L.L.C. | $245.28 | 2024-2025 | Sotyktu |
| Genzyme Corporation | $173.77 | 2024-2025 | |
| Ucb, INC. | $129.03 | 2024-2025 | Bimzelx |
| Pfizer INC. | $117.49 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $48.28 | 2024-2025 | |
| Lilly USA, LLC | $35.27 | 2024-2025 | Taltz, Olumiant, Ebglyss |
| Galderma Laboratories, L.P. | $31.66 | 2025 | Nemluvio |
| Biofrontera INC. | $31.47 | 2024-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Regeneron Healthcare Solutions, INC. | $28.25 | 2024 | Dupixent |
| Tactile Systems Technology INC | $18.11 | 2025 | Nimbl, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.